Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HMG2
Term | Name | Level | Count |
---|---|---|---|
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 10 | 1 |
GO:0000469 | cleavage involved in rRNA processing | 7 | 1 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 10 | 1 |
GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 8 | 1 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9 | 1 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 10 | 1 |
GO:0000966 | RNA 5'-end processing | 7 | 1 |
GO:0000967 | rRNA 5'-end processing | 9 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0022607 | cellular component assembly | 4 | 1 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 1 |
GO:0034462 | small-subunit processome assembly | 7 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034471 | ncRNA 5'-end processing | 8 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0036260 | RNA capping | 7 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043933 | protein-containing complex organization | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0065003 | protein-containing complex assembly | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 7 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0005488 | binding | 1 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 172 | 176 | PF00656 | 0.675 |
CLV_C14_Caspase3-7 | 218 | 222 | PF00656 | 0.519 |
CLV_C14_Caspase3-7 | 75 | 79 | PF00656 | 0.572 |
CLV_NRD_NRD_1 | 125 | 127 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.456 |
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.544 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.480 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.722 |
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.560 |
CLV_NRD_NRD_1 | 55 | 57 | PF00675 | 0.621 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.453 |
CLV_PCSK_FUR_1 | 158 | 162 | PF00082 | 0.414 |
CLV_PCSK_FUR_1 | 95 | 99 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 124 | 126 | PF00082 | 0.558 |
CLV_PCSK_KEX2_1 | 147 | 149 | PF00082 | 0.487 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.549 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.346 |
CLV_PCSK_KEX2_1 | 228 | 230 | PF00082 | 0.749 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 55 | 57 | PF00082 | 0.621 |
CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.449 |
CLV_PCSK_PC1ET2_1 | 124 | 126 | PF00082 | 0.616 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.676 |
CLV_PCSK_PC1ET2_1 | 228 | 230 | PF00082 | 0.749 |
CLV_PCSK_PC1ET2_1 | 94 | 96 | PF00082 | 0.506 |
CLV_PCSK_PC7_1 | 157 | 163 | PF00082 | 0.669 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.461 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.648 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.669 |
CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.662 |
CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.558 |
DOC_MAPK_gen_1 | 157 | 168 | PF00069 | 0.427 |
DOC_MAPK_gen_1 | 25 | 34 | PF00069 | 0.556 |
DOC_MAPK_gen_1 | 43 | 50 | PF00069 | 0.292 |
DOC_MAPK_MEF2A_6 | 28 | 36 | PF00069 | 0.499 |
DOC_MAPK_MEF2A_6 | 55 | 64 | PF00069 | 0.634 |
DOC_PP1_RVXF_1 | 31 | 37 | PF00149 | 0.564 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.628 |
DOC_USP7_UBL2_3 | 224 | 228 | PF12436 | 0.551 |
DOC_WW_Pin1_4 | 206 | 211 | PF00397 | 0.531 |
LIG_14-3-3_CanoR_1 | 167 | 174 | PF00244 | 0.464 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.717 |
LIG_Clathr_ClatBox_1 | 3 | 7 | PF01394 | 0.449 |
LIG_deltaCOP1_diTrp_1 | 68 | 73 | PF00928 | 0.533 |
LIG_FHA_1 | 207 | 213 | PF00498 | 0.714 |
LIG_FHA_1 | 221 | 227 | PF00498 | 0.592 |
LIG_LIR_Apic_2 | 7 | 12 | PF02991 | 0.539 |
LIG_LIR_Gen_1 | 113 | 121 | PF02991 | 0.512 |
LIG_LIR_Gen_1 | 68 | 76 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 113 | 117 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.500 |
LIG_Pex14_1 | 104 | 108 | PF04695 | 0.375 |
LIG_Pex14_2 | 108 | 112 | PF04695 | 0.492 |
LIG_SH2_CRK | 9 | 13 | PF00017 | 0.586 |
LIG_SH2_GRB2like | 19 | 22 | PF00017 | 0.579 |
LIG_SH2_NCK_1 | 9 | 13 | PF00017 | 0.586 |
LIG_SH2_SRC | 9 | 12 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.507 |
LIG_SH3_3 | 177 | 183 | PF00018 | 0.737 |
LIG_SH3_3 | 54 | 60 | PF00018 | 0.641 |
LIG_UBA3_1 | 61 | 67 | PF00899 | 0.526 |
MOD_CDK_SPK_2 | 206 | 211 | PF00069 | 0.531 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.643 |
MOD_CK1_1 | 206 | 212 | PF00069 | 0.684 |
MOD_CK2_1 | 113 | 119 | PF00069 | 0.487 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.556 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.719 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.726 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.521 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.696 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.491 |
MOD_PIKK_1 | 10 | 16 | PF00454 | 0.440 |
MOD_PKA_2 | 166 | 172 | PF00069 | 0.454 |
MOD_PKA_2 | 181 | 187 | PF00069 | 0.438 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.627 |
MOD_Plk_2-3 | 110 | 116 | PF00069 | 0.503 |
MOD_Plk_2-3 | 138 | 144 | PF00069 | 0.375 |
MOD_Plk_4 | 113 | 119 | PF00069 | 0.474 |
MOD_ProDKin_1 | 206 | 212 | PF00069 | 0.532 |
TRG_DiLeu_BaLyEn_6 | 57 | 62 | PF01217 | 0.636 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.504 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.651 |
TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.469 |
TRG_ER_diArg_1 | 146 | 148 | PF00400 | 0.581 |
TRG_ER_diArg_1 | 161 | 164 | PF00400 | 0.617 |
TRG_ER_diArg_1 | 42 | 44 | PF00400 | 0.480 |
TRG_ER_diArg_1 | 55 | 57 | PF00400 | 0.616 |
TRG_ER_diArg_1 | 95 | 98 | PF00400 | 0.544 |
TRG_ER_FFAT_2 | 68 | 78 | PF00635 | 0.552 |
TRG_NLS_Bipartite_1 | 147 | 164 | PF00514 | 0.584 |
TRG_NLS_MonoExtC_3 | 159 | 164 | PF00514 | 0.550 |
TRG_NLS_MonoExtC_3 | 223 | 228 | PF00514 | 0.722 |
TRG_NLS_MonoExtC_3 | 51 | 56 | PF00514 | 0.629 |
TRG_NLS_MonoExtC_3 | 93 | 98 | PF00514 | 0.483 |
TRG_NLS_MonoExtN_4 | 157 | 164 | PF00514 | 0.672 |
TRG_NLS_MonoExtN_4 | 49 | 56 | PF00514 | 0.625 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KHV3 | Bodo saltans | 42% | 96% |
A0A1X0NJ36 | Trypanosomatidae | 50% | 85% |
A0A3S7X912 | Leishmania donovani | 84% | 100% |
A3LVD5 | Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) | 23% | 67% |
A4IB33 | Leishmania infantum | 84% | 100% |
E9AEW3 | Leishmania major | 81% | 100% |
E9B619 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
Q148M8 | Bos taurus | 27% | 84% |
Q59YL9 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 26% | 72% |
Q6BSS5 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 23% | 77% |
Q6FWS2 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 29% | 75% |